Specialised Therapeutics to distribute European oncology drug
21 August, 2015Specialised Therapeutics Australia has formed an exclusive licence and commercialisation agreement with PharmaMar to market and distribute the oncology drug APLIDIN (plitidepsin) in Australia and New Zealand.
Prima receives milestone payment for anticancer antibody program
17 August, 2015Prima BioMed will receive a clinical milestone payment from Novartis relating to the latter's IMP701 LAG-3 antibody, which is being trialled for the treatment of cancer.
Medical Research Future Fund passes Senate
13 August, 2015Legislation for the Medical Research Future Fund (MRFF) has successfully passed through the Senate with bipartisan support, with assurance from the government that the fund will meet the needs of the medical research community.
Cancer screening pioneer joins Clinical Genomics
11 August, 2015Clinical Genomics has announced clinical diagnostics pioneer Howard Chandler as its inaugural Emeritus Scientist. Chandler is the inventor of the patient-friendly 'brush' form of faecal immunochemical test (FIT).
Rising market value for type 2 diabetes mellitus treatment
24 July, 2015The global market for type 2 diabetes mellitus (T2DM) therapeutics will rise in value from $23.5 billion in 2014 to around $39 billion by 2021, GBI Research has estimated.
Clinical Genomics announces Asia-Pacific distributors
16 July, 2015Biotechnology company Clinical Genomics has announced its newest distributors, expanding the reach of its colorectal cancer screening products in the Asia-Pacific region.
Entries open for mEYE World Photographic Competition
15 July, 2015Macular Disease Foundation Australia is calling for entries into the 2015 mEYE World Photographic Competition. The competition this year asks entrants to submit a photograph that captures the theme 'See My World'.
Nominate now for the 2015 CSL Florey Medal
26 June, 2015Nominations are now open for the 2015 CSL Florey Medal, awarded biennially to an Australian researcher who has made a significant lifetime achievement in biomedical science and/or human health advancement.
Experimental Parkinson's therapy shows promise
23 June, 2015Living Cell Technologies last week announced positive results from its Phase I/IIa clinical study of NTCELL, an experimental regenerative cell therapy being studied as a disease-modifying agent in Parkinson's disease.
New collaboration boosts Queensland's medical research
16 June, 2015QUT to have access to specialist health and medical research laboratories and facilities in the QIMR Berghofer complex.
Repurposing PPS
15 June, 2015Paradigm Biopharmaceuticals is raising funds to develop PPS (pentosan polysulphate sodium) as a superior treatment for BME (bone marrow oedema) and allergic rhinitis.
UniQuest and Janssen agreement focuses on immune system
15 June, 2015A new research and development deal is hoped will realise new treatments for ankylosing spondylitis psoriasis and inflammatory bowel disease.
Immune signals can predict cancer spread
15 June, 2015Australian researchers have discovered that the key to effective breast cancer treatment may lie in predicting the path the cancer plans to take.
IND reactivated for Prescient breast cancer drug
10 June, 2015The US FDA has reactivated the Investigational New Drug (IND) for the novel drug candidate PTX-100 (formerly known as GGTI-2418) in a phase Ib trial for the treatment of metastatic breast cancer.
How deadly ovarian cancer evades chemotherapy
03 June, 2015The largest complete DNA analysis of ovarian cancer in the world has revealed new insight into the genetic twists and turns a deadly form of the disease takes to outsmart chemotherapy. This groundbreaking work features contributions from several Australian facilities.
